Home › Compare › SHTDF vs DIVO

SHTDF vs DIVO: Dividend Comparison 2026

SHTDF yields 3.51% · DIVO yields 6.49%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 DIVO wins by $1.4K in total portfolio value
10 years
SHTDF
SHTDF
● Live price
3.51%
Share price
$2.68
Annual div
$0.09
5Y div CAGR
9.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$29.3K
Annual income
$1,273.49
Full SHTDF calculator →
DIVO
DIVO
● Live price
6.49%
Share price
$44.85
Annual div
$2.91
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$981.68
Full DIVO calculator →

Portfolio growth — SHTDF vs DIVO

📍 DIVO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSHTDFDIVO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SHTDF + DIVO cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
SHTDF pays
DIVO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SHTDF
Annual income on $10K today (after 15% tax)
$298.49/yr
After 10yr DRIP, annual income (after tax)
$1,082.47/yr
DIVO
Annual income on $10K today (after 15% tax)
$552.00/yr
After 10yr DRIP, annual income (after tax)
$834.43/yr
At 15% tax rate, SHTDF beats the other by $248.04/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SHTDF + DIVO for your $10,000?

SHTDF: 50%DIVO: 50%
100% DIVO50/50100% SHTDF
Portfolio after 10yr
$30.0K
Annual income
$1,127.58/yr
Blended yield
3.76%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SHTDF buys
0
DIVO buys
0
No recent congressional trades found for SHTDF or DIVO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSHTDFDIVO
Forward yield3.51%6.49% ✓
Annual dividend / share$0.09$2.91 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR9.8% ✓0%
Portfolio after 10y$29.3K$30.7K ✓
Annual income after 10y$1,273.49 ✓$981.68
Total dividends collected$7.5K$8.2K ✓
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: SHTDF vs DIVO ($10,000, DRIP)

YearSHTDF PortfolioSHTDF Income/yrDIVO PortfolioDIVO Income/yrGap
1← crossover$11,086$385.58$11,349$649.42$263.00 → DIVO
2$12,300$438.62$12,833$688.83$533.00 → DIVO
3$13,661$499.41$14,459$727.90$798.00 → DIVO
4$15,186$569.16$16,238$766.49$1.1K → DIVO
5$16,898$649.28$18,179$804.47$1.3K → DIVO
6$18,823$741.39$20,293$841.71$1.5K → DIVO
7$20,988$847.43$22,591$878.14$1.6K → DIVO
8$23,426$969.62$25,087$913.65$1.7K → DIVO
9$26,177$1,110.62$27,791$948.18$1.6K → DIVO
10$29,283$1,273.49$30,718$981.68$1.4K → DIVO

SHTDF vs DIVO: Complete Analysis 2026

SHTDF — Stock

Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail drug stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The Medical Devices segment distributes medical devices. The Retail Pharmacy segment operates and franchises a network of retail drug stores. As of December 31, 2021, this segment had 10,259 retail pharmacies. The Other Business segment engages in the production and sale of pharmaceutical products, chemical reagents, and laboratory supplies. The company also rents and manages properties; distributes medical instruments, Chinese herbal medicines, antibiotics, and biological products; and offers information technology development and medicine consultation, investment, goods and technology import and export, business consultation, health consultation, medical consultation, market information consultation and investigation, and convention and exhibition services. In addition, it manages medical project investment, consulting, and technology training activities. Sinopharm Group Co. Ltd. has a strategic partnership with I-Mab to enhance its commercial capabilities and commercialization transformation. The company was founded in 2003 and is headquartered in Shanghai, the People's Republic of China. Sinopharm Group Co. Ltd. is a subsidiary of Sinopharm Industrial Investment Co., Ltd.

Full SHTDF Calculator →

DIVO — ETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →
📬

Get this SHTDF vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SHTDF vs SCHDSHTDF vs JEPISHTDF vs OSHTDF vs KOSHTDF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.